Stoke Therapeutics, Inc. · NASDAQ:STOK
Rtw Investments, LP reported a 9.99% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Rtw Investments, LP reported a 9.99% stake in Stoke Therapeutics, Inc., 5,310,033 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 5,310,033
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RTW Investments, LP | 9.99% | 5,310,033 |
| Roderick Wong, M.D. | 9.99% | 5,310,033 |
Source
Related
- Stoke Therapeutics, Inc.
- Rtw Investments, LP
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026